Global: Pharmaceuticals Industry Guide

Global: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the Global Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences

Scope of the Report

• Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences
• Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Includes five-year forecasts for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences

Highlights

The global biotechnology market had total revenue of $200 billion in 2009, representing a compound annual growth rate (CAGR) of 10.2% for the period spanning 2005-2009.

The global generics market had total revenue of $149.7 billion in 2009, representing a compound annual growth rate (CAGR) of 11% for the period spanning 2005-2009.

The global life sciences tools and services market generated total revenues of $18.1 billion in 2009, representing a compound annual growth rate (CAGR) of 10.5% for the period spanning 2005-2009.

The global OTC pharmaceuticals market generated total revenues of $110.7 billion in 2009, representing a compound annual growth rate (CAGR) of 3.9% for the period spanning 2005-2009.

The global pharmaceuticals market is expected to have total revenue of $693 billion in 2010, representing a compound annual growth rate (CAGR) of 4.8% for the period spanning 2006-2010.

The global pharmaceuticals, biotechnology, and life sciences industry group generated total revenues of $1,071.7 billion in 2009, representing a compound annual growth rate (CAGR) of 6.7% for the period spanning 2005-2009.

Why you should buy this report

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Contents

GLOBAL BIOTECHNOLOGY

Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Five Forces Analysis
Market Forecasts

GLOBAL GENERICS

Market Overview
Market Value
Market Volume
Market Segmentation II
Five Forces Analysis
Market Forecasts

GLOBAL LIFE SCIENCES TOOLS & SERVICES

Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Five Forces Analysis
Market Forecasts

GLOBAL OTC PHARMACEUTICALS

Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Five Forces Analysis
Market Distribution
Market Forecasts

GLOBAL PHARMACEUTICALS

Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Five Forces Analysis
Market Forecasts

GLOBAL PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES

Market Overview
Market Value
Market Segmentation I
Market Segmentation II
Market Share
Five Forces Analysis
Market Forecasts

APPENDIX

Data Research Methodology
About Datamonitor
Disclaimer

LIST OF TABLES

Table 1: Global biotechnology market value: $ billion, 2005–09
Table 2: Global biotechnology market segmentation I:% share, by value, 2009
Table 3: Global biotechnology Market Segmentation II: % share, by value, 2009
Table 4: Global biotechnology market value forecast: $ billion, 2009–14
Table 5: Global generics market value: $ billion, 2005–09
Table 6: Global generics market volume: volume penetration, 2005–09
Table 7: Global generics Market Segmentation II: % share, by value, 2009
Table 8: Global generics market value forecast: $ billion, 2009–14
Table 9: Global generics market volume forecast: volume penetration, 2009–14
Table 10: Global life sciences tools & services market value: $ billion, 2005–09
Table 11: Global life sciences tools & services market segmentation I:% share, by value, 2009
Table 12: Global life sciences tools & services Market Segmentation II: % share, by value, 2009
Table 13: Global life sciences tools & services market share: % share, by value, 2009
Table 14: Global life sciences tools & services market value forecast: $ billion, 2009–14
Table 15: Global OTC pharmaceuticals market value: $ million, 2005–09
Table 16: Global OTC pharmaceuticals market segmentation I:% share, by value, 2009
Table 17: Global OTC pharmaceuticals Market Segmentation II: % share, by value, 2009
Table 18: Global OTC pharmaceuticals market share: % share, by value, 2009
Table 19: Global OTC pharmaceuticals market distribution: % share, by value, 2009
Table 20: Global OTC pharmaceuticals market value forecast: $ million, 2009–14
Table 21: Global pharmaceuticals market value: $ billion, 2006–10(e)
Table 22: Global pharmaceuticals market segmentation I:% share, by value, 2010(e)
Table 23: Global pharmaceuticals Market Segmentation II: % share, by value, 2010(e)
Table 24: Global pharmaceuticals market share: % share, by value, 2010(e)
Table 25: Global pharmaceuticals market value forecast: $ billion, 2010–15
Table 26: Global pharmaceuticals, biotechnology & life sciences industry value: $ billion, 2005–09
Table 27: Global pharmaceuticals, biotechnology & life sciences industry segmentation I:% share, by value, 2009
Table 28: Global pharmaceuticals, biotechnology & life sciences industry segmentation II: % share, by value, 2009
Table 29: Global pharmaceuticals, biotechnology & life sciences industry share: % share, by value, 2009
Table 30: Global pharmaceuticals, biotechnology & life sciences industry value forecast: $ billion, 2009–14

LIST OF FIGURES

Figure 1: Global biotechnology market value: $ billion, 2005–09
Figure 2: Global biotechnology market segmentation I:% share, by value, 2009
Figure 3: Global biotechnology Market Segmentation II: % share, by value, 2009
Figure 4: Forces driving competition in the global biotechnology market, 2009
Figure 5: Drivers of buyer power in the global biotechnology market, 2009
Figure 6: Drivers of supplier power in the global biotechnology market, 2009
Figure 7: Factors influencing the likelihood of new entrants in the global biotechnology market, 2009
Figure 8: Factors influencing the threat of substitutes in the global biotechnology market, 2009
Figure 9: Drivers of degree of rivalry in the global biotechnology market, 2009
Figure 10: Global biotechnology market value forecast: $ billion, 2009–14
Figure 11: Global generics market value: $ billion, 2005–09
Figure 12: Global generics market volume: volume penetration, 2005–09
Figure 13: Global generics Market Segmentation II: % share, by value, 2009
Figure 14: Forces driving competition in the global generics market, 2009
Figure 15: Drivers of buyer power in the global generics market, 2009
Figure 16: Drivers of supplier power in the global generics market, 2009
Figure 17: Factors influencing the likelihood of new entrants in the global generics market, 2009
Figure 18: Factors influencing the threat of substitutes in the global generics market, 2009
Figure 19: Drivers of degree of rivalry in the global generics market, 2009
Figure 20: Global generics market value forecast: $ billion, 2009–14
Figure 21: Global generics market volume forecast: volume penetration, 2009–14
Figure 22: Global life sciences tools & services market value: $ billion, 2005–09
Figure 23: Global life sciences tools & services market segmentation I:% share, by value, 2009
Figure 24: Global life sciences tools & services Market Segmentation II: % share, by value, 2009
Figure 25: Global life sciences tools & services market share: % share, by value, 2009
Figure 26: Forces driving competition in the global life sciences tools & services market, 2009
Figure 27: Drivers of buyer power in the global life sciences tools & services market, 2009
Figure 28: Drivers of supplier power in the global life sciences tools & services market, 2009
Figure 29: Factors influencing the likelihood of new entrants in the global life sciences tools & services market, 2009
Figure 30: Factors influencing the threat of substitutes in the global life sciences tools & services market, 2009
Figure 31: Drivers of degree of rivalry in the global life sciences tools & services market, 2009
Figure 32: Global life sciences tools & services market value forecast: $ billion, 2009–14
Figure 33: Global OTC pharmaceuticals market value: $ million, 2005–09
Figure 34: Global OTC pharmaceuticals market segmentation I:% share, by value, 2009
Figure 35: Global OTC pharmaceuticals Market Segmentation II: % share, by value, 2009
Figure 36: Global OTC pharmaceuticals market share: % share, by value, 2009
Figure 37: Forces driving competition in the global OTC pharmaceuticals market, 2009
Figure 38: Drivers of buyer power in the global OTC pharmaceuticals market, 2009
Figure 39: Drivers of supplier power in the global OTC pharmaceuticals market, 2009
Figure 40: Factors influencing the likelihood of new entrants in the global OTC pharmaceuticals market, 2009
Figure 41: Factors influencing the threat of substitutes in the global OTC pharmaceuticals market, 2009
Figure 42: Drivers of degree of rivalry in the global OTC pharmaceuticals market, 2009
Figure 43: Global OTC pharmaceuticals market distribution: % share, by value, 2009
Figure 44: Global OTC pharmaceuticals market value forecast: $ million, 2009–14
Figure 45: Global pharmaceuticals market value: $ billion, 2006–10(e)
Figure 46: Global pharmaceuticals market segmentation I:% share, by value, 2010(e)
Figure 47: Global pharmaceuticals Market Segmentation II: % share, by value, 2010(e)
Figure 48: Global pharmaceuticals market share: % share, by value, 2010(e)
Figure 49: Forces driving competition in the global pharmaceuticals market, 2010
Figure 50: Drivers of buyer power in the global pharmaceuticals market, 2010
Figure 51: Drivers of supplier power in the global pharmaceuticals market, 2010
Figure 52: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2010
Figure 53: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2010
Figure 54: Drivers of degree of rivalry in the global pharmaceuticals market, 2010
Figure 55: Global pharmaceuticals market value forecast: $ billion, 2010–15
Figure 56: Global pharmaceuticals, biotechnology & life sciences industry value: $ billion, 2005–09
Figure 57: Global pharmaceuticals, biotechnology & life sciences industry segmentation I:% share, by value, 2009
Figure 58: Global pharmaceuticals, biotechnology & life sciences industry segmentation II: % share, by value, 2009
Figure 59: Global pharmaceuticals, biotechnology & life sciences industry share: % share, by value, 2009
Figure 60: Forces driving competition in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 61: Drivers of buyer power in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 62: Drivers of supplier power in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 63: Factors influencing the likelihood of new entrants in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 64: Factors influencing the threat of substitutes in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 65: Drivers of degree of rivalry in the global pharmaceuticals, biotechnology & life sciences industry, 2009
Figure 66: Global pharmaceuticals, biotechnology & life sciences industry value forecast: $ billion, 2009–14
Skip to top